Balance Sheet Components

6 Months Ended

Jun. 30, 2026

Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consists of the following (in thousands):


	As of
	June 30, 2026		December 31, 2025
Accrued compensation	$	13,424	$	32,179
Accrued clinical and other research & development costs	19,871		22,283
Accrued manufacturing costs	10,659		5,336
Operating lease liability, current	10,084		9,463
Finance lease liability, current	97		83
Deferred research and development funding liability, current	19,975		21,101
Other accrued costs and current liabilities	4,166		7,401
Total accrued expenses and other current liabilities	$	78,276	$	97,846